cases of invasive squamous cell carcinoma, and nine pingueculae were chosen at random for PCR. In addition, six biopsies of inflamed conjunctiva that included epithelium but no malignancy or elastotic degeneration were tested. Material from six reactive lymph node biopsies (that is, no epithelium present) from the Ugandan population was also tested as negative controls.
Paraffin embedded tissue sections of 5 pm were dewaxed and digested with proteinase K. Aliquots of 5 d were amplified using primers to the L1 gene of HPV-16.'8 A hot start proce- HPV-16 DATA HPV-16 infection was detected in 7/20 (35%) of invasive carcinomas, 0/9 pingueculae, and 2/6 inflamed conjunctiva lesions (Fig 3) . None of six lymph nodes had HPV-16, supporting the specificity of the assay. HIV status was known for 32/35 patients whose lesions were tested for HPV-16: HIV and HPV-16 infections were not statistically significantly associated (but the numbers are small). 
CLINICAL DATA AND FOLLOW UP
Macroscopically the lesions ranged from 3 mm to over 3 cm in diameter (Figs 4, 5) . Some lesions as small as 4 mm were invasive carcinomas. In both countries all lesions (unless recurrent or large) were centred on the 180 degree meridian (at 3 or 9 o'clock to the cornea in the exposed area). The majority touched the corneal edge or overgrew it, but could be up to 5 mm distant. The surface was roughened or fungating, and this distinguished even the small carcinomas from benign lesions. Several had variable amounts of melanin pigment. In Uganda, three patients had tumours invading the globe and required enucleation, but the rest (including three recurrences) were removable by local excision under local anaesthesia, with superficial keratectomy if needed. In Malawi, five cases were recurrences and all were removed locally with cryotherapy to the wound edges. Healing was rapid, leaving almost no sign of surgery and corneal clarity returned. One Ugandan and two Malawian patients suffered later recurrences with invasion into the globe or orbit requiring extended removal. No distant metastases were seen. The duration of the lesions was reported to be between 1 week and 2 years, but patient recall seemed too unreliable to allow analysis. One documented patient was a 25-year-old female, HIV positive, who went from an insignificant nodule that was not excised to a carcinoma invading the globe within 8 months.
AIDS CASE SURVEIL-ANCE
Two of 38 Ugandan patients fulfilled theWHO AIDS case definition; in Malawi, 12 out of 30 evaluated patients did so, three having pulmonary tuberculosis. In Malawi there were no significant associations between histological diagnosis (CIN or invasive carcinoma) and the presence of AIDS defining signs.
Discussion
Conjunctival carcinoma has become a common clinical problem in these two countries. A similar increase has been seen in Nairobi, Kenya (M Wood, personal communication). The strong association between HIV positivity and conjunctival carcinoma is congruent with the increased frequency of carcinoma observed in Uganda since 1983 when HIV infection became common. In Uganda the odds ratio of conjunctival carcinoma associated with HIV infection is 13.1, similar to that in both previous studies.7 8 The control seroprevalence of 15.8% accords with 12.6% reported in 1991 for the region from which most cases came. 20 The testing of sera in Uganda was not uniform but 94% were done by two methods, and 83% of these included western blot, so a more uniform protocol would be unlikely to weaken the association. In Malawi there were no controls from which to calculate an odds ratio, but a minimum 25 of the 32 cases (78%) were HIV positive. For comparison, antenatal women in the same hospital had an HIV-1 seroprevalence of 33%. 21 Seventy eight per cent to 84% of carcinoma patients were HIV positive, and the population M BL 1 2 3 4 5 6 7 8 9 10 1112 Histopathologically, 46/47 invasive carcinomas were squamous and 1/47 mucoepidermoid. Ninety two per cent to 96% of all carcinomas were associated with elastosis as evidence of damage from sunlight. This is comparable with the 83% prevalence of elastosis in similar lesions in a USA study." Sixty Figure 4 HIVpositive patient with invasive carcinoma of the conjunctiva Figure 5 HIVnegative patient with smal invasive carcinoma of the conjunctiva.
seven per cent to 85% of invasive carcinomas had adjacent CIN in the biopsies as evidence of the continuum of CIN through to invasive lesions.
The aetiological role of HIV infection is unclear. There is no evidence that HIV is directly carcinogenic. One possibility is a failure of immune surveillance of malignant cells, which could follow from HIV mediated cellular immunosuppression and also, perhaps, from ultraviolet light itself.2" If so, a wider range of tumours might be expected. The only other ocular tumours observed in the study period were one melanoma and a few Kaposi's sarcomas, so the increase appears specific for conjunctival carcinoma.
Secondly, other infective agents may be inducing the carcinoma, and immunosuppression from HIV facilitates their activity. Human papilloma viruses are implicated in the increased incidence of anal and cervical carcinomas associated with HIV infection.24 25 
